463 related articles for article (PubMed ID: 35397496)
21. Cancer targeting peptides.
Kalmouni M; Al-Hosani S; Magzoub M
Cell Mol Life Sci; 2019 Jun; 76(11):2171-2183. PubMed ID: 30877335
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
23. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
[TBL] [Abstract][Full Text] [Related]
24. Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems.
Kondo E; Saito K; Tashiro Y; Kamide K; Uno S; Furuya T; Mashita M; Nakajima K; Tsumuraya T; Kobayashi N; Nishibori M; Tanimoto M; Matsushita M
Nat Commun; 2012 Jul; 3():951. PubMed ID: 22805558
[TBL] [Abstract][Full Text] [Related]
25. Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection.
Soudy R; Byeon N; Raghuwanshi Y; Ahmed S; Lavasanifar A; Kaur K
Mini Rev Med Chem; 2017; 17(18):1696-1712. PubMed ID: 26891935
[TBL] [Abstract][Full Text] [Related]
26. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
27. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
[TBL] [Abstract][Full Text] [Related]
28. Peptide-based glioma-targeted drug delivery vector gHoPe2.
Eriste E; Kurrikoff K; Suhorutšenko J; Oskolkov N; Copolovici DM; Jones S; Laakkonen P; Howl J; Langel Ü
Bioconjug Chem; 2013 Mar; 24(3):305-13. PubMed ID: 23350661
[TBL] [Abstract][Full Text] [Related]
29. Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.
Howl J; Jones S
Expert Rev Mol Med; 2015 Jan; 17():e1. PubMed ID: 26258595
[TBL] [Abstract][Full Text] [Related]
30. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
31. Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.
Zhang L; Zhang Y; Tai L; Jiang K; Xie C; Li Z; Lin YZ; Wei G; Lu W; Pan W
Acta Biomater; 2016 Sep; 42():90-101. PubMed ID: 27370905
[TBL] [Abstract][Full Text] [Related]
32. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
33. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
34. Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery.
Tian Y; Zhou S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1668. PubMed ID: 32929866
[TBL] [Abstract][Full Text] [Related]
35. 1988-2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research.
Gallo M; Defaus S; Andreu D
Arch Biochem Biophys; 2019 Jan; 661():74-86. PubMed ID: 30447207
[TBL] [Abstract][Full Text] [Related]
36. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
37. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide.
Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT
Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794
[TBL] [Abstract][Full Text] [Related]
38. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
[TBL] [Abstract][Full Text] [Related]
39. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
[TBL] [Abstract][Full Text] [Related]
40. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]